$IPA ImmunoPrecise
Good news and even better volume today. We should see this build a base around $10 - $12. Earnings on the 29th should be interesting.
VWAP rejected and momentum slowed down.
Long IPA. There is no way big pharma doesn't like this play.
VWAP rejected and momentum slowed down.
Long IPA. There is no way big pharma doesn't like this play.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.